IW
Integrated Wealth Management
13F filer · CIK 0002113155Reported Aug 11, 2026
Net buyer this quarter
13F portfolio value$94.7MU.S. long equity reported on 13F
Positions365 new · 2 closed
Net flow last quarter+$5.33MBuys minus sells
Top 10 positions weight17.4%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 11, 202636 positions | |||||
| OBONEZOne Bio, Corp. | $4.35M | 4.60% | Not reported | +186.3% | Q4 2025 |
| $3.34M | 3.53% | Not reported | New | Q2 2026 | |
| $2.28M | 2.41% | 0.00% | -2.1% | Q4 2025 | |
| $1.51M | 1.60% | 0.00% | -3.8% | Q4 2025 | |
| $926K | 0.98% | Not reported | +19.2% | Q1 2026 | |
| $894K | 0.94% | 0.00% | Not reported | Q4 2025 | |
| $818K | 0.86% | 0.00% | -3.9% | Q4 2025 | |
| $817K | 0.86% | Not reported | +10.2% | Q4 2025 | |
| $779K | 0.82% | 0.00% | -0.9% | Q4 2025 | |
| $739K | 0.78% | 0.00% | -3.5% | Q4 2025 | |
| $655K | 0.69% | 0.19% | -24.5% | Q4 2025 | |
| $624K | 0.66% | 0.01% | +22.1% | Q4 2025 | |
| $558K | 0.59% | 0.00% | +0.4% | Q4 2025 | |
| $506K | 0.53% | 0.00% | Not reported | Q4 2025 | |
| $497K | 0.52% | 0.00% | New | Q2 2026 | |
| $490K | 0.52% | Not reported | -0.5% | Q4 2025 | |
| $478K | 0.50% | 0.06% | -6.5% | Q4 2025 | |
| $466K | 0.49% | 0.00% | Not reported | Q4 2025 | |
| $418K | 0.44% | 0.00% | +4.1% | Q4 2025 | |
| $377K | 0.40% | 0.00% | Not reported | Q4 2025 | |
| $375K | 0.40% | 0.00% | +0.3% | Q4 2025 | |
| $371K | 0.39% | 0.00% | -0.4% | Q4 2025 | |
| $334K | 0.35% | 0.00% | -1.0% | Q4 2025 | |
| $326K | 0.34% | 0.00% | New | Q2 2026 | |
| $308K | 0.33% | 0.00% | Not reported | Q4 2025 | |
| $298K | 0.32% | 0.00% | -3.0% | Q4 2025 | |
| $281K | 0.30% | 0.00% | -0.6% | Q4 2025 | |
| $275K | 0.29% | 0.00% | -10.8% | Q4 2025 | |
| $253K | 0.27% | 0.00% | Not reported | Q4 2025 | |
| $230K | 0.24% | 0.00% | -0.4% | Q4 2025 | |
| $229K | 0.24% | Not reported | -3.6% | Q4 2025 | |
| $226K | 0.24% | 0.00% | +3.6% | Q4 2025 | |
| $223K | 0.24% | 0.00% | -4.7% | Q4 2025 | |
| $220K | 0.23% | 0.00% | New | Q2 2026 | |
| $217K | 0.23% | 0.00% | -31.0% | Q1 2026 | |
| $203K | 0.21% | 0.00% | New | Q2 2026 | |
| Q1 2026Reported Apr 23, 202633 positions | |||||
| $2.09M | 2.39% | 0.00% | -0.7% | Q4 2025 | |
| $2.04M | 2.34% | 0.00% | +6.0% | Q4 2025 | |
| OBONEZOne Bio, Corp. | $1.38M | 1.58% | Not reported | +15.0% | Q4 2025 |
| $1.37M | 1.57% | 0.00% | -9.7% | Q4 2025 | |
| $845K | 0.97% | 0.00% | +5.8% | Q4 2025 | |
| $812K | 0.93% | 0.00% | +98.1% | Q4 2025 | |
| $730K | 0.84% | 0.26% | -2.9% | Q4 2025 | |
| $724K | 0.83% | Not reported | +10.1% | Q4 2025 | |
| $679K | 0.78% | Not reported | New | Q1 2026 | |
| $670K | 0.77% | 0.00% | -2.4% | Q4 2025 | |
| $633K | 0.73% | 0.00% | -0.5% | Q4 2025 | |
| $607K | 0.70% | 0.01% | +27.8% | Q4 2025 | |
| $514K | 0.59% | 0.07% | -1.1% | Q4 2025 | |
| $510K | 0.59% | 0.00% | +7.0% | Q4 2025 | |
| $471K | 0.54% | Not reported | Not reported | Q4 2025 | |
| $455K | 0.52% | 0.00% | +2.5% | Q4 2025 | |
| $438K | 0.50% | 0.00% | Not reported | Q4 2025 | |
| $403K | 0.46% | 0.00% | +7.9% | Q4 2025 | |
| $395K | 0.45% | 0.00% | -2.0% | Q4 2025 | |
| $392K | 0.45% | 0.00% | -9.4% | Q4 2025 | |
| $360K | 0.41% | 0.00% | -4.0% | Q4 2025 | |
| $335K | 0.38% | 0.00% | +30.2% | Q4 2025 | |
| $332K | 0.38% | 0.00% | Not reported | Q4 2025 | |
| $325K | 0.37% | 0.00% | Not reported | Q4 2025 | |
| $318K | 0.36% | 0.00% | -20.2% | Q4 2025 | |
| $288K | 0.33% | 0.00% | -13.3% | Q4 2025 | |
| $266K | 0.31% | 0.00% | +0.2% | Q4 2025 | |
| $252K | 0.29% | 0.00% | +25.1% | Q4 2025 | |
| $250K | 0.29% | 0.00% | +44.1% | Q4 2025 | |
| $230K | 0.26% | 0.00% | -7.1% | Q4 2025 | |
| $208K | 0.24% | Not reported | Not reported | Q4 2025 | |
| $208K | 0.24% | 0.00% | New | Q1 2026 | |
| $204K | 0.23% | 0.00% | +0.3% | Q4 2025 | |
| Q4 2025Reported Mar 3, 202634 positions | |||||
| $2.06M | 2.32% | 0.00% | New | Q4 2025 | |
| $1.62M | 1.82% | 0.00% | New | Q4 2025 | |
| $1.49M | 1.68% | 0.00% | New | Q4 2025 | |
| OBONEZOne Bio, Corp. | $1.24M | 1.40% | Not reported | New | Q4 2025 |
| $1.04M | 1.17% | 0.00% | New | Q4 2025 | |
| $835K | 0.94% | 0.00% | New | Q4 2025 | |
| $800K | 0.90% | 0.26% | New | Q4 2025 | |
| $761K | 0.85% | 0.00% | New | Q4 2025 | |
| $692K | 0.78% | 0.00% | New | Q4 2025 | |
| $658K | 0.74% | Not reported | New | Q4 2025 | |
| $522K | 0.59% | 0.07% | New | Q4 2025 | |
| $496K | 0.56% | 0.00% | New | Q4 2025 | |
| $495K | 0.56% | Not reported | New | Q4 2025 | |
| $471K | 0.53% | 0.00% | New | Q4 2025 | |
| $444K | 0.50% | 0.00% | New | Q4 2025 | |
| $434K | 0.49% | 0.00% | New | Q4 2025 | |
| $434K | 0.49% | 0.01% | New | Q4 2025 | |
| $392K | 0.44% | 0.00% | New | Q4 2025 | |
| $373K | 0.42% | 0.00% | New | Q4 2025 | |
| $371K | 0.42% | 0.00% | New | Q4 2025 | |
| $338K | 0.38% | 0.00% | New | Q4 2025 | |
| $325K | 0.36% | 0.00% | New | Q4 2025 | |
| $317K | 0.36% | 0.00% | New | Q4 2025 | |
| $315K | 0.35% | 0.00% | New | Q4 2025 | |
| $312K | 0.35% | 0.00% | New | Q4 2025 | |
| $291K | 0.33% | 0.00% | New | Q4 2025 | |
| $282K | 0.32% | 0.00% | New | Q4 2025 | |
| $260K | 0.29% | 0.00% | New | Q4 2025 | |
| $246K | 0.28% | 0.00% | New | Q4 2025 | |
| $236K | 0.27% | 0.00% | New | Q4 2025 | |
| $210K | 0.24% | 0.00% | New | Q4 2025 | |
| $204K | 0.23% | 0.00% | New | Q4 2025 | |
| $203K | 0.23% | Not reported | New | Q4 2025 | |
| $202K | 0.23% | 0.00% | New | Q4 2025 | |
Premium opens every quarter this fund has filed